The immune suppression that characterizes human helminth infections can hinder the development of protective immunity or help reduce pathogenic inflammation. Signaling through the T cell costimulator GITR counteracts immune down-regulation by augmenting effector T cell responses and abrogating suppression by Foxp3 + regulatory T cells. Thus, super-physiological antibodymediated GITR co-stimulation represents a novel therapy for promoting protective immunity towards parasitic helminths, whilst blocking physiological GITR-GITRL interactions may provide a mechanism for dampening pathogenic Th2 inflammation. We investigated the superphysiological and physiological role of the GITR-GITRL pathway in the development of protective and pathogenic Th2 responses in murine infection models of filariasis (Litomosoides sigmodontis) and schistosomiasis (Schistosoma mansoni). Providing super-physiological GITR co-stimulation using an agonistic anti-GITR mAb over the first 12 days of L. sigmodontis infection initially increased the quantity of Th2 cells as well as their ability to produce Th2 cytokines. However, as infection progressed the Th2 responses reverted to normal infection levels and parasite killing remained unaffected. Despite the Th2 promoting role of super-physiological GITR co-stimulation, antibody-mediated blockade of the GITR-GITRL pathway did not affect Th2 cell priming or maintenance during L. sigmodontis infection. Blockade of GITR-GITRL interactions during the acute egg-phase of S. mansoni infection resulted in reduced Th2 responses, but this effect was confined to the spleen and did not lead to changes in liver pathology. Thus, although super-physiological GITR co-stimulation can therapeutically enhance Th2 responses, physiological GITR-GITRL interactions are not required for the development of Th2-mediated resistance or pathology in murine models of filariasis and schistosomiasis.
Introduction
Human helminth infections are characterized by immune suppression resulting in parasite survial and chronic infection (1) (2) (3) . Chronically infected filarial and schistosome patients present impaired immune responses as shown by reduced IL-5 and IFN-γ, and occasionally IL-4, production in response to parasite antigens (4) (5) (6) (7) . Although some elements of immune suppression are reversible upon drug-mediated clearance (6, 8) , drug treatments do not induce immune protection against parasite challenge and individuals rapidly become reinfected. Strategies to induce long-term protective immunity are therefore needed that can counteract infection-induced immune regulation.
The Glucocorticoid-Induced TNF Receptor-related protein (GITR) is a co-stimulatory receptor and a member of the tumor necrosis factor receptor superfamily (9) (10) (11) . It is constitutively expressed at high levels on Foxp3 + regulatory T cells (Tregs) and at low levels on naïve CD4 + T cells, and expression increases in both cell populations upon activation (12) . The ligand for GITR (GITRL) is highly expressed on activated plasmatocytoid DC (13, 14) and macrophages (15) . Co-stimulation through GITR augments CD4 + effector T (Teff) cell responses (12, 16) and by enhancing CD4 + Teff cell activation can abrogate Foxp3 + Treg mediated suppression (14, 17) . Therefore, GITR co-stimulation provides a potential strategy for counteracting immune regulation and boosting immune responses. We and others have demonstrated that agonistic anti-GITR mAb treatment can enhance immunity to helminth parasites (18, 19) , and similar results have been found with other infections (20) (21) (22) and tumors (23, 24) . As such there is growing interest in employing GITR co-stimulation as a novel vaccine adjuvant (25) (26) (27) (28) . On the counter side, GITR ligation can exacerbate pathology during bacterial or protozoan infections (29, 30) , suggesting that blocking GITR-GITRL interactions could be used to alleviate pathology. Most studies have focussed on the effects of agonistic anti-GITR co-stimulation, yet these super-physiological effects of GITR ligation might be quite different from natural ligation through GITRL. Few studies have shown a physiological role for GITR-GITRL interactions during immune challenge, all of which are Th1 related (13, (31) (32) (33) . Thus, the physiological roles of GITR are not well defined, particularly in regard to Th2 responses.
Infection of resistant (C57BL/6) and susceptible (BALB/c) mice with the filarial nematode Litomosoides sigmodontis provides a unique model to dissect out the mechanisms of immune regulation in Th2-mediated resistance to helminths (34) . In a complementary system, infection of mice with the trematode Schistosoma mansoni allows the study of pathogenic Th2 responses towards the highly immunogenic Th2-driving eggs that become trapped in tissue microvasculature, such as the liver, resulting in granuloma formation (35) . We have demonstrated that L. sigmodontis infection induces an early Foxp3 + Treg response that in susceptible mice inhibits protective immunity and promotes parasite survival (19, 36, 37) . Resistant C57BL/6 mice show equivalent early Foxp3 + Treg responses, but in contrast they simultaneously present a more active CD4 + Foxp3 − Teff cell response with upregulation of GITR. This raises an interesting question of what role GITR plays in priming and maintaining Th2 effector responses, and/or in their resistance to Foxp3 + Treg mediated suppression. The balance of which may influence protective immunity during filarial infection.
Although susceptible BALB/c mice develop a down-regulated immune phenotype leading to a fully developed patent infection 55 -60 days p.i. (19, 36, 37) , defined by the presence of transmission stage microfilariae (Mf) circulating within the blood (34), they do eventually overcome immune-regulation resulting in late-phase killing and clearance of L. sigmodontis after 70 days (34, 38, 39) . GITR expression on BALB/c CD4 + Foxp3 − T cells increases during the later stages of infection (19, 36) , and super-physiological GITR co-stimulation can be used therapeutically alongside depleting CD4 + CD25 + Foxp3 + Tregs to enhance parasite killing (19) . Thus, GITR co-stimulation may also be involved in the reversal of immune-regulation and late-phase parasite killing following patency.
co-stimulation during immune priming using an agonistic anti-GITR mAb increased Th2 responses towards L. sigmodontis in susceptible BALB/c mice. However, these augmented Th2 responses were short-lived and did not result in a long-term enhancement of protective immunity. Blocking physiological GITR-GITRL interactions with a neutralizing anti-GITRL mAb during L. sigmodontis infection did not inhibit Th2 priming in resistant C57BL/6 mice, nor the late-phase parasite-clearance in susceptible BALB/c mice. Whilst GITRL blockade during the egg-deposition stage of S. mansoni infection had a partial effect on the expansion of splenic IL-4 producing Th2 cells, it had no significant impact on liver granuloma formation. Thus, although superphysiological GITR co-stimulation enhanced Th2 responses during filarial infection, physiological GITR-GITRL interactions were neither a prerequisite for resistance, nor a requirement for the induction or maintenance of Th2 responses. Similarly, GITR-GITRL interactions were not required for the development of Th2-mediated immunopathology during S. mansoni infection.
Materials and Methods

Animals, infections, antigen, and immunizations
Female BALB/c, C57BL/6 and BALB/c 4get IL-4gfp reporter mice (courtesy of Markus Mohrs, The Trudeau Institute) (40) were bred in-house and maintained under specific pathogen-free conditions at the University of Edinburgh. Mice were used at 6-12 weeks of age, and all animal work was conducted in accordance with the Animals (Scientific Procedures) Act 1986. The L. sigmodontis life cycle was maintained in gerbils using the mite vector Ornithonyssus bacoti (41) . Mice were infected s.c. on the upper back with 25 L. sigmodontis L3 larvae. Adult parasites were recovered by lavage. L. sigmodontis antigen (LsAg) was prepared by collecting the PBS-soluble fraction of homogenized adult male and female worms. Biomphalaria glabrata snails infected with S. mansoni were obtained from F.
Lewis (Biomedical Research Institute, Rockville, MD). Experimental mice were infected percutaneously with approximately 30 S. mansoni cercariae. S. mansoni eggs were quantified following liver digestion in 4% potassium hydroxide buffer per gram liver tissue at 37°C. To measure liver granulomas, paraffin embedded liver sections were stained with Masson's trichrome and the area of each granuloma containing a single egg calculated using a compound microscope (LEICA) and LEICA analysis software (LAS). From this the average granuloma size for each individual mouse was calculated. S. mansoni eggs were isolated from C57BL/6 mouse livers and stored at −80°C. S. mansoni soluble egg Ag was prepared in-house as previously described (42) . Mice were immunized s.c. in the footpad with 1500 S. mansoni eggs.
In vivo antibody and BrdU treatments
Mice received i.p. injections of 1 mg agonistic anti-GITR mAb (DTA-1, in house) (17) on d0 and d7 of L. sigmodontis infection. To block GITRL, mice were given i.p. injections with 200 μg anti-GITRL mAb (MIH44, in house) (43) every three days. Treatment started on d0 or d59 of L. sigmodontis infection, d0 of S. mansoni egg injection, and d36 following S. mansoni infection. An equivalent dose of rat IgG (Sigma-Aldrich) was used as control. For mansoni studies. To purify GFP − CD4 + T cells from IL-4gfp mice tLN cells were enriched for CD4 + T cells by negative selection using anti-CD8 (53-6.72), anti-B220 (RAB632), anti-MHC class II (M5/114.15.2), anti-Gr1 (RB6-8C5) and anti-F4/80 (A3-1), followed by sheep anti-rat IgG Dynal Beads (Invitrogen). Cells were stained with allophycocyanin-conjugated anti-CD4 (RM4-5) and GFP − CD4 + T cells purified using a FACSAria flow sorter (BectonDickinson). To isolate liver mononuclear cells the liver was diced and digested at 37°C with 250 μg/ml Collagenase D and 10 μg/ml DNase in Hanks' medium supplemented with 50 U/ ml penicillin-50 μg/ml streptomycin. To stop the enzymatic digestion 100 μl 0.1 M EDTA pH 7.3 was added. To obtain a single-cell suspension the digest was passed through a 70 μm cell strainer (BD Biosciences). Leukocytes were isolated by resuspension in 33% isotonic Percoll (GE Healthcare) and centrifugated at 700 g. For restimulation with LsAg (10μg/ml) or S. mansoni SEA (15μg/ml) whole tLN cells were cultured at 5×10 5 cells/well and spleen cells at 1×10 6 cells/well. Purified GFP − CD4 + T cells were cultured at 5×10 4 cells/well with 1×10 6 irradiated (30 Gy) naïve splenocytes. Supernatants were harvested at 72 hours. To measure intra-cellular cytokines cells were stimulated for 4 hours with 0.5 μg/ml PMA (Sigma-Aldrich) and 1 μg/ml Ionomycin (Sigma-Aldrich), with 10 μg/ml Brefeldin A added for the final 2 hours (Sigma-Aldrich).
Flow cytometry
The following antibodies were used: Alexafluor700-conjugated anti-CD4 (RM4-5), polyclonal anti-GFP (Ebioscience), Alexafluor488-conjugated goat anti-rabbit IgG (Invitrogen), phycoerythrin-conjugated anti-IL-4 (11B11), Alexafluor647-conjugated anti-IL-13 (ebio13A, Ebioscience), allophycocyanin-conjugated anti-IL-5 (TRFK5), E450-conjugated anti-IFN-γ (XMG1.2, Ebioscience), Fluorescein isothiocyanate-conjugated anti-GITR (DTA-1, in house), Fluorescein isothiocyanate-conjugated anti-BrdU with DNase (B44) and allophycocyanin -conjugated anti-Foxp3 (FJK-16s, Ebioscience). Non-specific binding was blocked with 4 μg of rat IgG/1×10 6 cells. Intracellular staining for Foxp3 was performed with a Foxp3-staining buffer kit (eBioscience). For intracellular cytokine staining dead cells were excluded using Aqua Dead Cell Stainkit (Molecular Probes), and the cells fixed and permeabilized using the BD Cytofix/Cytoperm kit. Flow cytometric acquisition was performed on a FACSCanto II or LSR II (BD Biosciences) and data were analyzed using Flowjo Software (Tree Star). Reagents were obtained from BD Biosciences unless otherwise stated.
Cytokine and antibody ELISA
Antibody pairs used for cytokine ELISA were IL-4 (11B11/BVD6-24G2); IL-5 (TRFK5/ TRFK4); IL-10 (JES5-2A5/SXC-1); IFN-γ (R4-6A2/XMG1.2); capture anti-IL-13 (38213, R&D systems); and biotinylated polyclonal anti-IL-13 (Peprotech). Recombinant murine IL-4, IL-5, IL-10, IFN-γ (Sigma-Aldrich), and IL-13 (R&D Systems) were used as standards. Biotin detection antibodies were used with ExtrAvidin-alkaline phosphatase conjugate (Sigma-Aldrich) and Sigma FastTM p-nitrophenyl phosphate substrate (SigmaAldrich). To measure L. sigmodontis specific antibodies ELISA plates (NUNC) were coated with 5 μg/ml LsAg diluted in 0.45M NaHCO 3 /0.18M Na 2 CO 3 (Sigma-Aldrich). Plates were incubated with serial dilutions of serum, and a representative dilution from the linear section of the dilution curve selected for each isotype. Detection of Ab isotypes was performed using HRP-conjugated anti-mouse IgG1, IgG2a or IgM (Southern Biotechnology Associates) and ABTS peroxidase substrate system (KPL).
data from multiple repeat experiments, or experiments containing more than two groups, was performed using ANOVA followed by Tukey's post-hoc tests. When using two-way ANOVA to combine data from multiple experiments it was verified that there were no significant qualitative interactions between experimental and treatment effects. For nonparametric data the unpaired Mann-Whitney test was used. Figures depict means when parametric tests were used and medians when non-parametric tests were used.
Results
Th2 responses are retarded during the initial stages of L. sigmodontis infection
Th2 responses are critical for resistance towards L. sigmodontis (44, 45) . However, it has been difficult to accurately quantify Th2 responses in the early stages of infection. To track Th2 cell development during L. sigmodontis infection susceptible BALB/c 4get IL-4gfp reporter mice (46) were infected and the percentage of CD4 + IL-4gfp + Th2 cells in the pleural cavity (infection site) and tLN quantified over the course of infection. The development of Th2 responses during the early infection stages was slow with no initial increase over naives in the proportion of IL-4gfp + Th2 cells in the pleural cavity at d6 p.i., and only a weak, albeit significant, 2-fold increase in the proportion of IL-4gfp + Th2 cells at d12 p.i. (Fig. 1A) . The weak nature of the d12 increase was notable by the fact that it did not reach significance within every individual experiment, although significant when metaanalysis was used to combine data from multiple experiments. Not until the later stages of infection did the proportion of IL-4gfp + Th2 cells gradually increase with a 6-fold expansion by d40 p.i., when adult parasites have developed, and a 17-fold increase after the onset of patency at d60 p.i. (Fig 1A) . A similar pattern was found within the tLN, with a modest initial expansion followed by a gradual increase to reach a 4-fold up-regulation at d60 p.i. (Fig. 1B) . Thus, the initial Th2 response to L. sigmodontis is remarkably slow to emerge, becoming robust only during the later infection stages.
Therapeutic administration of anti-GITR during immune priming enhances the magnitude of the Th2 response
We have previously shown that resistance to L. sigmodontis infection in C57BL/6 mice is associated with increased expression of GITR on CD4 + Foxp3 − Teff cells during the early infection stages, whilst susceptible BALB/c mice fail to up-regulate GITR and show reduced CD4 + Foxp3 − Teff cell proliferation (36) . To test the hypothesis that providing superphysiological GITR co-stimulation could be used to boost the initial Th2 responses and reverse susceptibility, we infected BALB/c IL-4gfp reporter mice with L. sigmodontis and treated them with agonistic anti-GITR mAb at d0 and d7 p.i. Treatment resulted in a 60% increase in the frequency of IL-4gfp + Th2 cells in the pleural cavity 12 days p.i. (Fig. 2A) . This increment was restricted to the infection site as although anti-GITR treatment increased the percentage of IL-4gfp + Th2 cells in the tLN this was independent of infection ( Fig. 2B) . Despite the augmented Th2 differentiation, anti-GITR did not increase the numbers of total cells or CD4 + T cells in the tLN or pleural cavity (data not shown).
In 4get reporter mice, GFP + cells are those that express IL-4 mRNA and are competent to produce IL-4, but the GFP label does not necessarily mark the production of IL-4 protein (40) . To confirm that anti-GITR treatment increases the production of Th2 cytokines we assessed the ability of IL-4gfp + Th2 cells in the pleural cavity to produce IL-4, IL-5, and IL-13 by intra-cellular staining for protein. Whilst infection alone at this early timepoint only caused a minor non-significant increase in the proportion of IL-4gfp + Th2 cells producing IL-5 and IL-13 (Fig 2D-E) , anti-GITR treatment of infected mice significantly increased the percentage of IL-4gfp + Th2 cells producing IL-4, IL-5 and IL-13 ( Fig. 2C-E tLN in response to infection, it did result in increased L. sigmodontis Ag-specific IL-5 production following in vitro restimulation of tLN cells (Fig. 2F) . IL-4 and IL-13 were not consistently detectable following in vitro restimulation emphasizing the weak nature of the early Th2 response (data not shown). In line with Th2 induction, L. sigmodontis infection tends to reduce the proportion of CD4 + T cells producing IFN-γ, however, in addition to its effects on Th2 immunity, anti-GITR treatment increased the proportion of pleural cavity CD4 + T cells producing IFN-γ 12 days p.i. (Fig. 2G ).
To investigate whether anti-GITR treatment also boosts humoral immunity, we determined the levels of L. sigmodontis Ag-specific antibodies in the serum 12 days p.i.. Despite enhancing the cellular Th2 response, anti-GITR treatment did not result in increased production of the Th2 antibody isotype IgG1 (Fig. 2H) . However, the increased production of IFN-γ was associated with elevated levels of serum IgG2a (Fig. 2I) . Serum IgM, IgG2b, and IgG3 were unaffected by anti-GITR treatment (data not shown).
Thus, super-physiological GITR co-stimulation during immune priming enhances both Th1 and Th2 responses to L. sigmodontis, with the increased Th2 immunity at the infection site due to both elevated numbers of IL-4gfp + Th2 cells and increased functional quality of the Th2 population as measured by their production of Th2 cytokines.
Therapeutic administration of anti-GITR during immune priming fails to increase parasite killing and results in a long-term enhancement of Th1, but not Th2, immunity
For anti-GITR treatment to be effective as an adjuvant or therapeutic agent it would need to induce a long-term change in protective immunity. Therefore, we asked whether agonistic anti-GITR treatment results in a permanent or temporary enhancement of Th2 responses. Susceptible BALB/c IL-4gfp + reporter mice were treated with anti-GITR on d0 and d7 p.i. and autopsied at d60 when Mf are circulating in the bloodstream.
By d60 p.i. L. sigmodontis infected mice have established a stronger Th2 response with 34±9% of CD4 + T cells in the pleural cavity expressing IL-4gfp (Fig 3A) compared to 5±5% at d12 (Fig. 1A) . Despite the early boosting effect of anti-GITR treatment on Th2 responses there were no differences in the proportion (Fig. 3A-B ) or number (results not shown) of IL-4gfp + Th2 cells between anti-GITR treated and IgG infected mice by 60 days p.i.. There were also no differences in the L. sigmodontis Ag-specific production of IL-5 ( Fig. 3C ), IL-4 or IL-13 (data not shown) by tLN following in vitro restimulation. Consistent with the failure to induce a long-term increase in Th2 immunity, adult parasite burdens and Mf counts in peripheral blood remained unaffected following anti-GITR treatment (Figs. 3D-E).
In agreement with the transitory nature of the enhanced cellular Th2 response we did not find any long-term effect of anti-GITR treatment on L. sigmodontis-specific serum levels of IgG1 (Fig. 3F) . However, L. sigmodontis-specific IgG2a was still elevated in the sera at d60 p.i. (Fig. 3G) , and IFN-γ production by purified tLN IL-4gfp − non-Th2 cells was enhanced, albeit in an antigen non-specific manner (Fig. 3H) . Thus, the augmenting effects of anti-GITR treatment on Th2 priming appear to be temporary, and do not result in increased parasite killing. In contrast, even though L. sigmodontis infection mainly induces a Th2 response anti-GITR treatment resulted in a minor, but long-term, enhancement of Th1 immunity. interactions are required for the development of Th2 responses and resistance to filarial infections, we treated L. sigmodontis infected C57BL/6 mice over the first 12 days of infection with an anti-GITRL mAb that has been shown to block GITRL activity in vivo (13, 24, 43) .
GITR-GITRL interactions
GITRL blockade failed to reduce the proportion of CD4 + Foxp3 − Teff cells proliferating in vivo in response to infection, thus GITR-GITRL interactions could not explain the enhanced effector T cell response of resistant C57BL/6 mice (Fig. 4A) . Similarly, GITR-GITRL interactions were not required for the induction of Th2 responses as the production of L. sigmodontis Ag-specific IL-5 and IL-13 by tLN cells was unaffected (Fig. 4B, 4C ). GITRL blockade also failed to impact on the resistant phenotype with both control and anti-GITRL treated mice showing similar parasite recoveries at d47 p.i. (data not shown). These data suggest that although super-physiological GITR co-stimulation can enhance Th2 responses during priming, physiological GITR-GITRL interactions are not required for Th2 priming following L. sigmodontis infection.
GITR-GITRL interactions are not required for late-phase killing of L. sigmodontis
Although patency is associated with immune down-regulation (19, 36, 37) , BALB/c mice show a late-phase killing response and clear infection after 70 days (34, 38, 39) . We have found that expression of GITR on Foxp3 − Teff cells at the infection site increases as infection progresses, and that treating infected mice with agonistic anti-GITR antibody during established infection can promote protective immunity (19, 36) . These results raise the hypothesis that late-phase killing is due to increasing levels of GITR co-stimulation naturally boosting Th2 cell responses and leading to a reversal in immune regulation.
To investigate this possibility, L. sigmodontis infected susceptible BALB/c mice, either wild-type or IL-4gfp reporter mice, were treated with a blocking anti-GITRL mAb from d60-80 p.i.. Despite high levels of GITR expression (19, 37) , blockade of GITRL was not found to impact on parasite burden or Mf levels 82 days p.i. (Fig. 5A-B) . Accordingly, no differences were seen in the total number of IL-4gfp + Th2 cells in the pleural cavity (Fig.  5C ) or the tLN (Fig. 5D ), or the proportion of pleural cavity IL-4gfp + Th2 cells producing IL-4 and IL-5 protein (data not shown). In vitro L. sigmodontis Ag-specific production of IL-5 ( Fig. 5E ) and IL-4 (data not shown) by tLN cells also remained unaltered. Thus, GITR-GITRL interactions are not required for Th2 maintenance or late-phase killing during L. sigmodontis infection.
GITR-GITRL interactions are partially required for Th1 and Th2 responses during S. mansoni infection
Infection with S. mansoni results in immunopathology when eggs become trapped in the liver microvasculature, resulting in immune inflammation and granuloma formation (35) . We found that expression of GITR is strongly upregulated on CD4 + Foxp3 − Teff cells in the spleen and liver at the peak of egg-induced inflammation (week 8 p.i.) (Fig. 6A-B) suggesting that GITR signaling is potentiating the inflammatory Th2 response. We therefore tested whether blocking GITR-GITRL interactions can be used to moderate Th2 mediated inflammation and granuloma formation during S. mansoni infection.
As early infection with L. sigmodontis larvae induces a relatively weak Th2 response and increases in IL-4 protein are difficult to detect, we injected S. mansoni eggs s. the draining popliteal LN (Fig. 6C) , as well as the total number of IL-4gfp + Th2 cells producing IL-4 (data not shown) remained unaltered.
To investigate whether GITR-GITRL interactions promote egg-induced Th2 responses during S. mansoni infection, BALB/c IL-4gfp reporter mice were treated with blocking anti-GITRL mAb from the stage of initial egg deposition (wk 5 p.i.) until the time of peak inflammation (wk 8 p.i.). Blockade of GITRL resulted in a significant 43% reduction in the number of IL-4gfp + Th2 cells expressing IL-4 protein in the spleen (Fig. 6D) . Despite the reduced number of IL-4gfp + Th2 cells secreting IL-4 protein in the spleen there was no effect on S. mansoni egg Ag-specific splenic production of IL-4, IL-5, IL-10 or IL-13 following in vitro restimulation (data not shown). Consistent with a partial reduction in Th2 responses, GITRL blockade had no effect on the proportion of IL-4gfp + Th2 cells secreting IL-4 protein in the liver (Fig. 6E) , and also no effect on the size of egg-induced liver granulomas (Fig. 6F) . As well as a diminished Th2 response, there was a small but consistently significant reduction in the proportion of IFN-γ producing CD4 + T cells in the spleen (Fig. 6G) and liver (Fig. 6H) . Thus, in contrast to L. sigmodontis infection, blockade of GITR-GITRL interactions partially reduces both Th2 and Th1 responses towards S. mansoni.
GITR-GITRL interactions are not required for Foxp3 + Treg expansion following helminth infection
L. sigmodontis infection results in the rapid expansion of GITR + Foxp3 + Tregs at the infection site in both susceptible and resistant mice (36) . There are conflicting reports that GITR co-stimulation promotes Foxp3 + Treg expansion (13, 18, 32, 43, 47) so to test whether GITR-GITRL interactions are responsible for the initial Foxp3 + Treg expansion GITRL was blocked over the first 12 days of L. sigmodontis infection in resistant C57BL/6 mice. As previously shown there was an increased percentage of CD4 + T cells expressing Foxp3 in the pleural cavity of L. sigmodontis infected mice, but this was unaffected by blockade of GITRL (Fig. 7A ). In the converse experiment, treating susceptible BALB/c mice with agonistic anti-GITR mAb on d0 and d7 p.i. also failed to affect the percentage of CD4 + T cells expressing Foxp3 (Fig. 7B) . Similarly, blockade of GITRL during the acute egg phase of S. mansoni infection (wk 5-8 p.i.) had no effect on Foxp3 + Treg expansion in the spleen (Fig. 7C) or liver (Fig. 7D) . Thus, GITR-GITRL interactions do not play a major role in the expansion of Foxp3 + Tregs during L. sigmodontis or S. mansoni infections.
Discussion
Co-stimulation of GITR through agonistic mAb is known to augment effector T cell responses (10, 16) , overcome Foxp3 + Treg mediated suppression (14, 17) , and boost resistance to infection with helminths, protozoa, and viruses (18) (19) (20) (21) 48) , demonstrating the potential for targeting GITR as a therapeutic adjuvant. In contrast to this super-physiological GITR co-stimulation, understanding of the physiological role of GITR is limited, particularly in Th2 settings. In the present study we investigated both the superphysiological and physiological role of the GITR-GITRL pathway in the development and maintenance of protective and pathogenic Th2 and Foxp3 + CD4 + Treg responses in murine models of filariasis and schistosomiasis. Providing super-physiological GITR co-stimulation using agonistic anti-GITR mAb during immune priming initially augmented Th2 responses towards the filarial nematode L. sigmodontis. However, this effect was temporary with the Th2 response reverting to normal infection levels by the onset of patency (d60 p.i.) and failed to enhance parasite killing. Despite the Th2 enhancing effect of agonistic anti-GITR treatment, GITRL blockade failed to affect Th2 cell priming, and only showed a partial effect on Th2 cell maintenance during S. mansoni infection. Thus, although superphysiological GITR co-stimulation can enhance Th2 responses, GITR-GITRL interactions van are not essential for the priming or maintenance of Th2 responses under physiological conditions.
Filarial parasites have been shown to rapidly suppress host immunity (36, 49) , and in agreement with this we found that the expansion of IL-4gfp + Th2 cells was relatively weak in the pleural cavity (infection site) and draining LN of susceptible BALB/c mice over the first 12 days of infection. This contrasts with the rapid expansion of CD4 + Foxp3 + Tregs seen by d7 p.i. in filarial infections (36, 50) . Consistent with published work (19, 51) the IL-4gfp + Th2 cells increased during the later stages of infection. Agonistic anti-GITR treatment given over the first 12 days of infection increased the quantity of IL-4gfp + Th2 cells at the infection site, and also their functional quality as represented by an increased ability of the IL-4gfp + Th2 cells to secrete Th2 cytokines. Thus, GITR co-stimulation can be used therapeutically to boost both the quantity and quality of Th2 responses towards infection; however, this was not sufficient to enhance killing of L. sigmodontis.
The potential for using super-physiological GITR co-stimulation as a therapeutic adjuvant has been successfully applied in a variety of tumor (52-54) and infection settings (18, 20) . In these contexts the protective effects were seen within or shortly after the duration of anti-GITR treatment, and only one study has addressed the long-term effects of superphysiological GITR co-stimulation (25) . Immune therapies that successfully improve protection towards L. sigmodontis often result in relatively slow killing, taking one or two months for the effects on parasite survival to become detectable, and are associated with a long-term enhancement of Th2 immunity (19, 36, 37) . Our data with L. sigmodontis
indicates that the Th2 boosting effects of agonistic anti-GITR treatment are temporary. Thus, the lack of efficacy of super-physiological GITR co-stimulation on L. sigmodontis infection is likely related to the temporary nature of its Th2 promoting effect suggesting that filarial parasites are relatively resistant to short-term enhancement of Th2 responses. This indicates that for a therapy to be successful it needs to be able to induce a long-term change in the protective Th2 response.
Agonistic anti-GITR treatment has been used as an adjuvant to induce long-term antibody responses towards viral antigens (25) , raising a question of why the enhancing effect on Th2 immunity towards L. sigmodontis was temporary. Filarial parasites induce a variety of regulatory mechanisms to inhibit host immunity (1-3), in particular inducing strong Foxp3 + Treg responses (19, 36, 37, 50, 55, 56) . One possibility is that once anti-GITR treatment is discontinued parasite-induced immune suppression reasserts itself countering the enhanced Th2 response. In support of this we find that during established L. sigmodontis infection the efficacy of super-physiological GITR co-stimulation can be enhanced by simultaneously depleting CD25 + Foxp3 + Tregs (19 In summary, this work indicates that super-physiological GITR co-stimulation can be used to therapeutically enhance the quantity and quality of Th2 responses during helminth infection. However, the temporary nature of its boosting effect is a potential limit to its efficacy and more work is needed to identify optimal treatment regimes to promote longterm changes in immunity. Although agonistic anti-GITR treatment enhanced Th2 responses, physiological GITR-GITRL interactions were not fundamentally required for the priming or maintenance of Th2 responses towards either L. sigmodontis or S. mansoni.
Thus, the potent immune stimulatory properties that have been reported for superphysiological GITR co-stimulation may not accurately reflect its actual physiological roles. 
